Rockville, MD (Marketwired) - Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in vaccines, oncology, and general medicine clinical research held a graduation ceremony yesterday for Accelovance Academy's inaugural class of Clinical Research Associates (CRAs).
In response to the shortage of CRAs in the research industry, Accelovance established the Accelovance Academy to internally develop high quality CRAs through a regimented and consistent training program. Accelovance partnered with Life Science Training Institute (LSTI) to develop a 7-week intensive CRA training program. The individuals graduating as part of the inaugural class were hand selected based on their background and education from a pool of over 75 applicants. As part of the new CRA training program, students completed practical work applications, passed all assessments with scores of 90% or above, and will perform on-site work alongside senior experienced CRAs. Accelovance is delighted to announce the first graduating class of 6 new CRAs who have successfully completed this rigorous program.
"This is a milestone achievement demonstrating the foundational investment made by Accelovance for our clients and clinical trials thereby resulting in well trained, motivated CRAs to ensure exceptional execution in project delivery. Thanks to our relationship with LSTI and an outstanding team here at Accelovance, we have built a training program that is able to be leveraged moving forward to address an industry need," said Accelovance's Senior Vice President, Vita Lanoce. "It is great to see the enthusiasm and drive of these highly-educated individuals and their desire to become a CRA," said Joann Peters, Director of Clinical Operations at Accelovance. "They have a true appreciation of how hard it is to break into the clinical research industry and are thankful for the opportunity Accelovance has provided."
About Life Science Training Institute
The Life Science Training Institute (LSTI) provides actionable, practical instruction to life science professionals in topics ranging from pre-clinical concerns to post-marketing requirements. Since 2013, LSTI has educated over 15,000 industry professionals using innovative online, in-person, and blended learning solutions. LSTI believes in tailoring content in a way that will be absorbed by adult learners and is relatable to their specific work environment. Utilizing the best Subject Matter Experts (SMEs) in pharmaceutical, biopharmaceutical, and medical device development, LSTI can assist your firm in developing lasting, customized curriculum that you own, allowing you to train staff internally long after initial delivery. For more information on how LTSI can help you train staff while saving time and money, connect with us at www.lifesciencetraininginstitute.com.
Accelovance, Inc., headquartered in Rockville, MD, is an industry award-winning global Contract Research Organization (CRO) focused primarily in vaccine, oncology, and general medicine clinical research. As a clinical services provider to the pharmaceutical and biotechnology industries, Accelovance offers comprehensive clinical development services including management and implementation of Phase I-IV clinical trials, supportive research centers, and a clinical engagement solution utilized for recruitment, post-marketing surveillance, and long-term survival follow-up. For more information, visit the company's Web site at www.accelovance.com.